Fact vs fallacy: the anti-vaccine discussion reloaded LB Stolle, R Nalamasu, JV Pergolizzi, G Varrassi, P Magnusson, ... Advances in therapy 37, 4481-4490, 2020 | 92 | 2020 |
Curcumin in turmeric: Basic and clinical evidence for a potential role in analgesia UJ Eke‐Okoro, RB Raffa, JV Pergolizzi Jr, F Breve, R Taylor Jr, ... Journal of Clinical Pharmacy and Therapeutics 43 (4), 460-466, 2018 | 64 | 2018 |
COVID-19 and NSAIDS: a narrative review of knowns and unknowns JV Pergolizzi, G Varrassi, P Magnusson, JA LeQuang, A Paladini, ... Pain and therapy 9, 353-358, 2020 | 53 | 2020 |
The current clinically relevant findings on COVID-19 pandemic JV Pergolizzi Jr, P Magnusson, JA LeQuang, F Breve, A Paladini, ... Anesthesiology and Pain Medicine 10 (2), 2020 | 48 | 2020 |
Can NSAIDs and acetaminophen effectively replace opioid treatment options for acute pain? JV Pergolizzi, P Magnusson, JA LeQuang, F Breve, R Taylor, C Wollmuth, ... Expert Opinion on Pharmacotherapy 22 (9), 1119-1126, 2021 | 44 | 2021 |
Potential neurological manifestations of COVID-19: a narrative review JV Pergolizzi Jr, RB Raffa, G Varrassi, P Magnusson, JA LeQuang, ... Postgraduate medicine 134 (4), 395-405, 2022 | 39 | 2022 |
Cocaine and cardiotoxicity: a literature review JV Pergolizzi Jr, P Magnusson, JAK LeQuang, F Breve, G Varrassi Cureus 13 (4), 2021 | 22 | 2021 |
Opioid therapy in cancer patients and survivors at risk of addiction, misuse or complex dependency JV Pergolizzi Jr, P Magnusson, PJ Christo, JA LeQuang, F Breve, ... Frontiers in Pain Research 2, 691720, 2021 | 20 | 2021 |
Illicitly manufactured fentanyl entering the United States J Pergolizzi, P Magnusson, JAK LeQuang, F Breve Cureus 13 (8), 2021 | 18 | 2021 |
Transdermal buprenorphine for acute pain in the clinical setting: a narrative review JV Pergolizzi Jr, P Magnusson, JA LeQuang, F Breve, K Mitchell, ... Journal of pain research, 871-879, 2021 | 18 | 2021 |
Exploring the connection between sleep and cluster headache: a narrative review JV Pergolizzi, P Magnusson, JA LeQuang, C Wollmuth, R Taylor, F Breve Pain and Therapy 9, 359-371, 2020 | 16 | 2020 |
Mobile narcotic treatment programs: on the road again? F Breve, L Batastini, JAK LeQuang, G Marchando Cureus 14 (3), 2022 | 14 | 2022 |
What do we need to know about rising rates of idiopathic pulmonary fibrosis? A narrative review and update JV Pergolizzi Jr, JA LeQuang, M Varrassi, F Breve, P Magnusson, ... Advances in Therapy 40 (4), 1334-1346, 2023 | 13 | 2023 |
Pharmacotherapeutic management of trigeminal neuropathic pain: an update JV Pergolizzi Jr, C Gharibo, P Magnusson, F Breve, JA LeQuang, ... Expert Opinion on Pharmacotherapy 23 (10), 1155-1164, 2022 | 13 | 2022 |
Cocaethylene: when cocaine and alcohol are taken together J Pergolizzi, F Breve, P Magnusson, JAK LeQuang, G Varrassi Cureus 14 (2), 2022 | 13 | 2022 |
Treating apnea of prematurity J Pergolizzi, A Kraus, P Magnusson, F Breve, K Mitchell, R Raffa, ... Cureus 14 (1), 2022 | 13 | 2022 |
Opioids in the elderly patients with cognitive impairment: a narrative review M Rekatsina, A Paladini, O Viswanath, I Urits, D Myrcik, J Pergolizzi, ... Pain and Therapy 11 (2), 381-394, 2022 | 12 | 2022 |
The new stealth drug on the street: a narrative review of xylazine as a street drug J Pergolizzi Jr, JAK LeQuang, P Magnusson, TL Miller, F Breve, ... Cureus 15 (6), 2023 | 11 | 2023 |
Old drugs and new challenges: a narrative review of nitazenes J Pergolizzi Jr, R Raffa, JAK LeQuang, F Breve, G Varrassi Cureus 15 (6), 2023 | 11 | 2023 |
The sigma enigma: A narrative review of sigma receptors J Pergolizzi, G Varrassi, M Coleman, F Breve, DK Christo, PJ Christo, ... Cureus 15 (3), 2023 | 11 | 2023 |